Summary

Breath Molecular Diagnostic Device Market Trends and Forecast
The future of the global breath molecular diagnostic device market looks promising with opportunities in the hospital, clinic, and physical examination center markets. The global breath molecular diagnostic device market is expected to grow with a CAGR of 8.2% from 2025 to 2031. The major drivers for this market are the increasing incidence of respiratory and metabolic, the rising development of sensitive and accurate sensors, and the growing shift towards personalized treatments.

• Lucintel forecasts that, within the type category, VOCs type is expected to witness the highest growth over the forecast period.
• Within the application category, the hospital is expected to witness the highest growth.
• In terms of region, APAC is expected to witness the highest growth over the forecast period.
Gain valuable insights for your business decisions with our comprehensive 150+ page report. Sample figures with some insights are shown below.

Emerging Trends in the Breath Molecular Diagnostic Device Market
The breath molecular diagnostic device market is experiencing several emerging trends that are shaping its future. Innovations in sensor technology, artificial intelligence (AI), and molecular analysis are making these devices more accurate, affordable, and accessible. As the market evolves, new applications for breath analysis are being discovered, expanding the potential of these non-invasive diagnostic tools. These trends are enhancing disease detection, improving patient outcomes, and transforming the landscape of medical diagnostics.
• Integration of Artificial Intelligence (AI) for Data Analysis: The integration of AI into breath molecular diagnostic devices is a key trend that is improving the accuracy and efficiency of disease detection. AI algorithms are being used to analyze complex breath samples, identifying biomarkers associated with various diseases such as lung cancer and diabetes. By processing large volumes of data in real-time, AI enhances the precision of breath tests, enabling early detection of conditions that would otherwise go unnoticed. The continued development of AI-powered devices is set to revolutionize the healthcare sector, making diagnostics faster, more reliable, and widely accessible.
• Advancements in Sensor Technology: Advances in sensor technology are enabling breath molecular diagnostic devices to detect a broader range of diseases with greater sensitivity. New sensors are being developed that can detect minute chemical compounds in the breath, which are indicative of specific diseases. These innovations are improving the reliability of breath tests and expanding their potential applications. As sensors become more sophisticated, breath-based diagnostic devices are becoming more accurate and capable of detecting conditions such as cancer, infections, and metabolic disorders at earlier stages, when treatment options are most effective.
• Point-of-Care Testing and Home Use: There is a growing trend toward the development of breath molecular diagnostic devices that can be used for point-of-care testing and at-home diagnostics. These portable devices allow for quick, easy, and non-invasive disease detection, which is particularly valuable in remote or underserved areas. The ability to perform diagnostic tests at home or in outpatient settings reduces the need for hospital visits and makes early detection more accessible. This trend is improving patient convenience and enabling more timely medical interventions, reducing the burden on healthcare systems and enhancing patient outcomes.
• Focus on Early Cancer Detection: Early detection of cancer is a major driving force in the development of breath molecular diagnostic devices. Advances in breath analysis are enabling the detection of biomarkers that are associated with various types of cancer, including lung, gastric, and colorectal cancer. The non-invasive nature of breath tests makes them an attractive option for regular screening and early diagnosis, which can significantly improve survival rates. As these technologies become more accurate and widely available, they will play a crucial role in reducing cancer mortality rates by enabling earlier treatment.
• Global Expansion and Market Accessibility: As the demand for breath molecular diagnostic devices grows, there is a focus on expanding their accessibility across global markets. Companies are working to make these devices more affordable and available to diverse populations, particularly in developing countries where access to traditional diagnostic methods may be limited. International collaborations and government support for medical technology innovations are driving this expansion. The global reach of breath molecular diagnostics is expected to increase significantly, offering widespread benefits for disease prevention, early detection, and treatment in both developed and emerging markets.
The emerging trends in the breath molecular diagnostic device market, including AI integration, advancements in sensor technology, and the shift toward point-of-care testing, are reshaping the landscape of medical diagnostics. These innovations are driving more accurate, faster, and affordable diagnostic solutions, improving early detection capabilities, and expanding the accessibility of these technologies worldwide. As these trends continue to evolve, breath molecular diagnostics are poised to revolutionize disease detection and management.

Recent Developments in the Breath Molecular Diagnostic Device Market
The breath molecular diagnostic device market has seen numerous key developments in recent years, driven by advancements in sensor technology, artificial intelligence, and the growing demand for non-invasive diagnostic tools. These developments are significantly improving the accuracy, speed, and accessibility of disease detection, especially for conditions such as cancer, respiratory diseases, and metabolic disorders. The following are five key developments that are shaping the future of this market.
• FDA Approvals for Breath Diagnostic Devices: Recent approvals by the U.S. Food and Drug Administration (FDA) for breath molecular diagnostic devices have been a significant development in the market. These approvals have paved the way for broader clinical adoption of non-invasive diagnostic technologies, enabling the detection of conditions such as lung cancer and COVID-19. FDA-approved devices are setting new standards for regulatory compliance, safety, and efficacy, which will help accelerate the growth of the market by providing assurance to healthcare providers and patients alike.
• Integration of Artificial Intelligence for Enhanced Accuracy: The integration of artificial intelligence (AI) into breath molecular diagnostic devices has significantly improved their diagnostic capabilities. AI algorithms are now being used to process breath samples more effectively, enhancing the detection of disease biomarkers and increasing the accuracy of test results. This development is especially important for detecting diseases at early stages when they are most treatable. AI-driven breath diagnostics are set to become more widely used in clinical settings due to their efficiency, precision, and ability to process complex data in real time.
• Development of Portable Breath Analyzers: Portable breath analyzers have significantly advanced the market. These compact, user-friendly devices allow for rapid, non-invasive testing in various settings, such as clinics, homes, and remote areas. The portability of these analyzers makes them ideal for point-of-care diagnostics, providing immediate results without the need for laboratory testing. As these devices become more affordable and accessible, they will be crucial in improving early detection and monitoring of diseases like lung cancer and asthma.
• Advancements in Cancer Detection: Advances in breath analysis technologies for cancer detection have been a focal point of recent developments. Researchers have discovered specific biomarkers in the breath that are associated with the presence of cancer, particularly lung cancer. The identification of these biomarkers has led to the development of more precise breath diagnostic devices that can detect cancer at early stages. These innovations are expected to improve survival rates by enabling early diagnosis and intervention.
• Collaborations Between Technology Companies and Healthcare Providers: Strategic collaborations between technology companies and healthcare providers have played a significant role in the development of breath molecular diagnostic devices. These partnerships are focused on leveraging advanced technologies, such as AI and machine learning, to improve the accuracy and efficiency of breath-based diagnostics. Collaborative efforts are accelerating the integration of these devices into clinical practice and driving the global expansion of breath molecular diagnostic technologies.
Recent developments in the breath molecular diagnostic device market, such as FDA approvals, AI integration, and the creation of portable analyzers, are revolutionizing the healthcare industry by offering non-invasive, accurate, and efficient diagnostic solutions. These innovations are expected to make disease detection faster and more accessible, driving the growth of the market and improving patient outcomes across the globe.
Strategic Growth Opportunities in the Breath Molecular Diagnostic Device Market
The breath molecular diagnostic device market presents several growth opportunities, particularly in areas such as early disease detection, point-of-care testing, and global market expansion. Companies in this sector can capitalize on these opportunities by developing innovative technologies and expanding their reach into new markets. The following are five key growth opportunities by application in the breath molecular diagnostic device market.
• Early Cancer Detection: Early cancer detection is a significant growth opportunity in the breath molecular diagnostic device market. Advances in breath analysis technologies are enabling the identification of cancer biomarkers at early stages, allowing for earlier intervention and improved patient outcomes. Companies that focus on developing breath-based diagnostic devices for cancer detection are well-positioned to capture a share of the growing market for non-invasive cancer screening.
• Point-of-Care Testing for Respiratory Diseases: Point-of-care testing for respiratory diseases, such as asthma and chronic obstructive pulmonary disease (COPD), is a major growth area. Breath molecular diagnostic devices can provide rapid and accurate diagnoses of these conditions, enabling timely treatment and improving patient management. Expanding the use of these devices in outpatient settings, clinics, and even at-home testing can reduce healthcare costs and improve patient outcomes.
• Chronic Disease Monitoring: Breath molecular diagnostic devices have the potential to transform the management of chronic diseases, such as diabetes and gastrointestinal disorders. These devices can be used to monitor disease progression and treatment effectiveness by detecting specific biomarkers in the breath. This growth opportunity is especially relevant in regions with high rates of chronic disease, where non-invasive monitoring solutions can alleviate the burden on healthcare systems.
• Global Market Expansion: Expanding access to breath molecular diagnostic devices in emerging markets presents a significant growth opportunity. As healthcare systems in developing countries improve, there is increasing demand for affordable and accessible diagnostic technologies. Companies that focus on reducing the cost of breath analyzers and expanding their distribution networks can capture a significant share of these growing markets.
• AI and Machine Learning Integration: The integration of AI and machine learning into breath molecular diagnostic devices represents a growth opportunity that can enhance the accuracy and efficiency of disease detection. By leveraging AI to analyze complex breath samples, companies can create more sophisticated diagnostic devices that offer faster, more reliable results. As AI technology continues to improve, this trend will play a crucial role in the future of breath molecular diagnostics.
The breath molecular diagnostic device market is experiencing significant growth opportunities across various applications, from early cancer detection to global market expansion. Companies that focus on advancing technology, improving accessibility, and expanding into emerging markets will be well-positioned to capitalize on these opportunities and contribute to the widespread adoption of breath-based diagnostics. These growth opportunities will drive innovation in the market and improve global healthcare outcomes.
Breath Molecular Diagnostic Device Market Driver and Challenges
The breath molecular diagnostic device market is influenced by several technological, economic, and regulatory factors. While advances in sensor technology, AI, and molecular diagnostics are driving growth, there are also challenges related to cost, regulatory hurdles, and market adoption. Understanding these drivers and challenges is crucial for navigating the market and ensuring the widespread use of breath molecular diagnostic devices.
The factors responsible for driving the breath molecular diagnostic device market include:
1. Technological Advancements in Sensor Technology: The rapid advancement in sensor technology is one of the key drivers in the breath molecular diagnostic device market. New sensors can detect lower concentrations of disease biomarkers, enhancing the sensitivity and accuracy of breath tests. These technological innovations are improving the reliability of breath-based diagnostics and expanding their applications, particularly in the detection of cancers, respiratory diseases, and metabolic disorders.
2. Increasing Demand for Non-Invasive Testing: The growing preference for non-invasive diagnostic methods is driving the demand for breath molecular diagnostic devices. Patients and healthcare providers are increasingly seeking alternatives to invasive procedures such as biopsies and blood tests. Breath-based diagnostics offer a painless, fast, and cost-effective solution for disease detection, especially for conditions like lung cancer, asthma, and gastrointestinal disorders.
3. Rising Incidence of Respiratory Diseases and Cancer: The increasing prevalence of respiratory diseases and cancer worldwide is driving the demand for diagnostic devices that can detect these conditions early. Breath molecular diagnostics offer a non-invasive way to monitor and diagnose diseases like lung cancer, asthma, and chronic obstructive pulmonary disease (COPD). As the burden of these diseases grows, the need for early detection tools is becoming more pressing.
4. Government Support for Healthcare Innovation: Governments worldwide are providing support for healthcare innovations, including the development of breath molecular diagnostic devices. This support includes funding for research and development, regulatory incentives, and initiatives to promote the adoption of advanced diagnostic technologies. Government backing is helping accelerate the commercialization and adoption of breath-based diagnostic devices in clinical settings.
5. AI and Machine Learning Advancements: The incorporation of AI and machine learning into breath molecular diagnostic devices is driving market growth. These technologies enable faster, more accurate analysis of breath samples, improving the precision of disease detection. As AI technologies evolve, they will continue to enhance the functionality of breath diagnostic devices, making them more effective in clinical practice.
Challenges in the breath molecular diagnostic device market are:
1. High Development and Production Costs: The high costs associated with developing and producing breath molecular diagnostic devices are a significant challenge. These devices require advanced technology, such as high-precision sensors and AI integration, which can be expensive to develop and manufacture. High production costs may limit the affordability and accessibility of these devices, particularly in low-income regions.
2. Regulatory Barriers and Approval Processes: The regulatory landscape for medical devices, including breath molecular diagnostic devices, can be complex and time-consuming. Navigating the approval processes in different regions requires significant resources and can delay product commercialization. Companies must ensure that their devices meet stringent regulatory requirements, which can be a barrier to market entry and adoption.
3. Market Adoption and Awareness: Despite the promising potential of breath molecular diagnostics, widespread market adoption remains a challenge. Healthcare providers and patients must be educated on the benefits and accuracy of these devices. Overcoming skepticism and gaining trust from the medical community will be crucial for the successful integration of breath diagnostics into routine clinical practice.
The breath molecular diagnostic device market is driven by advancements in sensor technology, increasing demand for non-invasive testing, and the rising incidence of respiratory diseases and cancer. However, challenges related to high development costs, regulatory hurdles, and market adoption remain significant. Addressing these challenges will be crucial for the widespread adoption of breath molecular diagnostic devices, ensuring their potential to revolutionize healthcare by offering affordable, accurate, and non-invasive diagnostic solutions.
List of Breath Molecular Diagnostic Device Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies breath molecular diagnostic device companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the breath molecular diagnostic device companies profiled in this report include-
• Niox Group
• Headway
• Sunvou Medical Electronics
• Caire (NGK)
• Richen Holding
• Meridian Bioscience
• Capnia

Breath Molecular Diagnostic Device Market by Segment
The study includes a forecast for the global breath molecular diagnostic device market by type, application, and region.
Breath Molecular Diagnostic Device Market by Type [Value from 2019 to 2031]:
• C13 Type
• NO Type
• H2/CO Type
• VOCs Type

Breath Molecular Diagnostic Device Market by Application [Value from 2019 to 2031]:
• Hospitals
• Clinics
• Physical Examination Centers
• Other



Breath Molecular Diagnostic Device Market by Region [Value from 2019 to 2031]:
• North America
• Europe
• Asia Pacific
• The Rest of the World



Country Wise Outlook for the Breath Molecular Diagnostic Device Market
The breath molecular diagnostic device market is experiencing significant growth, driven by the demand for non-invasive, rapid, and accurate diagnostic tools. These devices are revolutionizing the field of medical diagnostics, offering a promising alternative to traditional testing methods, such as blood tests and biopsies. Innovations in sensor technology and molecular analysis are enabling breath-based diagnostic devices to detect a wide range of diseases, including cancer, infections, and metabolic disorders. This market is expanding globally, with key developments in countries like the United States, China, Germany, India, and Japan, where research and healthcare integration are advancing rapidly.
• United States: The United States has become a leader in the development and deployment of breath molecular diagnostic devices. Recent advancements include the approval of several breath-based diagnostic technologies that can detect diseases such as lung cancer, asthma and infections like COVID-19. The U.S. Food and Drug Administration (FDA) has granted clearance for several non-invasive breath analyzers, enabling broader use in clinical settings. Furthermore, significant investments in research and collaborations between tech companies and healthcare providers are accelerating the development of breath-based diagnostic devices that offer real-time disease detection with higher accuracy.
• China: In China, the breath molecular diagnostic device market is growing rapidly, with a focus on early detection of respiratory diseases, including lung cancer and chronic obstructive pulmonary disease (COPD). Research institutions and companies are working to improve the accuracy and sensitivity of breath-based tests, with the goal of making them more affordable and accessible to the general population. The Chinese government has also been actively supporting the development of medical devices, providing incentives and funding for innovations in breath diagnostics. The market is expected to grow significantly due to increasing healthcare awareness and investment in biotechnology.
• Germany: Germany is leading the way in Europe in the development of breath molecular diagnostic devices, especially in the detection of cancer and infectious diseases. German companies and research institutions are focused on enhancing the precision of breath tests by integrating advanced sensors and AI technologies. Additionally, there is growing interest in using breath biomarkers to monitor chronic conditions, such as diabetes and gastrointestinal diseases. The country’s robust healthcare infrastructure and intense focus on medical technology innovation are helping drive the adoption of breath molecular diagnostic devices in both clinical and home healthcare settings.
• India: The Indian breath molecular diagnostic device market is still in the early stages but is poised for rapid growth. With a large and diverse population, there is significant potential for non-invasive diagnostic technologies, especially for diseases prevalent in the region, such as tuberculosis and diabetes. Researchers in India are working on developing affordable breath analyzers to cater to the needs of the healthcare system, which faces resource limitations in rural areas. The government is encouraging the development of medical technologies that can reduce the burden on the country’s healthcare infrastructure and improve early disease detection.
• Japan: Japan is making significant strides in the field of breath molecular diagnostics, particularly in the detection of gastric cancer, lung cancer, and metabolic disorders. Japan’s government and medical institutions are investing heavily in breath analyzer research, focusing on improving the sensitivity and specificity of these devices. Companies are also exploring the use of artificial intelligence to analyze breath samples more efficiently. Japan’s aging population and high cancer incidence rates are driving the demand for innovative, non-invasive diagnostic solutions, positioning the country as a key player in the global breath molecular diagnostic market.
Features of the Global Breath Molecular Diagnostic Device Market
Market Size Estimates: Breath molecular diagnostic device market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.
Segmentation Analysis: Breath molecular diagnostic device market size by type, application, and region in terms of value ($B).
Regional Analysis: Breath molecular diagnostic device market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different types, applications, and regions for the breath molecular diagnostic device market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the breath molecular diagnostic device market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.


This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the breath molecular diagnostic device market by type (C13 type, NO type, H2/CO type, and VOCs type), application (hospitals, clinics, physical examination centers, and other), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

ページTOPに戻る

Table of Contents

Table of Contents

1. Executive Summary

2. Market Overview
2.1 Background and Classifications
2.2 Supply Chain

3. Market Trends & Forecast Analysis
3.1 Macroeconomic Trends and Forecasts
3.2 Industry Drivers and Challenges
3.3 PESTLE Analysis
3.4 Patent Analysis
3.5 Regulatory Environment
3.6 Global Breath Molecular Diagnostic Device Market Trends and Forecast

4. Global Breath Molecular Diagnostic Device Market by Type
4.1 Overview
4.2 Attractiveness Analysis by Type
4.3 C13 Type: Trends and Forecast (2019-2031)
4.4 NO Type: Trends and Forecast (2019-2031)
4.5 H2/CO Type: Trends and Forecast (2019-2031)
4.6 VOCs Type: Trends and Forecast (2019-2031)

5. Global Breath Molecular Diagnostic Device Market by Application
5.1 Overview
5.2 Attractiveness Analysis by Application
5.3 Hospitals: Trends and Forecast (2019-2031)
5.4 Clinics: Trends and Forecast (2019-2031)
5.5 Physical Examination Centers: Trends and Forecast (2019-2031)
5.6 Other: Trends and Forecast (2019-2031)

6. Regional Analysis
6.1 Overview
6.2 Global Breath Molecular Diagnostic Device Market by Region

7. North American Breath Molecular Diagnostic Device Market
7.1 Overview
7.2 North American Breath Molecular Diagnostic Device Market by Type
7.3 North American Breath Molecular Diagnostic Device Market by Application
7.4 United States Breath Molecular Diagnostic Device Market
7.5 Mexican Breath Molecular Diagnostic Device Market
7.6 Canadian Breath Molecular Diagnostic Device Market

8. European Breath Molecular Diagnostic Device Market
8.1 Overview
8.2 European Breath Molecular Diagnostic Device Market by Type
8.3 European Breath Molecular Diagnostic Device Market by Application
8.4 German Breath Molecular Diagnostic Device Market
8.5 French Breath Molecular Diagnostic Device Market
8.6 Spanish Breath Molecular Diagnostic Device Market
8.7 Italian Breath Molecular Diagnostic Device Market
8.8 United Kingdom Breath Molecular Diagnostic Device Market

9. APAC Breath Molecular Diagnostic Device Market
9.1 Overview
9.2 APAC Breath Molecular Diagnostic Device Market by Type
9.3 APAC Breath Molecular Diagnostic Device Market by Application
9.4 Japanese Breath Molecular Diagnostic Device Market
9.5 Indian Breath Molecular Diagnostic Device Market
9.6 Chinese Breath Molecular Diagnostic Device Market
9.7 South Korean Breath Molecular Diagnostic Device Market
9.8 Indonesian Breath Molecular Diagnostic Device Market

10. ROW Breath Molecular Diagnostic Device Market
10.1 Overview
10.2 ROW Breath Molecular Diagnostic Device Market by Type
10.3 ROW Breath Molecular Diagnostic Device Market by Application
10.4 Middle Eastern Breath Molecular Diagnostic Device Market
10.5 South American Breath Molecular Diagnostic Device Market
10.6 African Breath Molecular Diagnostic Device Market

11. Competitor Analysis
11.1 Product Portfolio Analysis
11.2 Operational Integration
11.3 Porter’s Five Forces Analysis
• Competitive Rivalry
• Bargaining Power of Buyers
• Bargaining Power of Suppliers
• Threat of Substitutes
• Threat of New Entrants
11.4 Market Share Analysis

12. Opportunities & Strategic Analysis
12.1 Value Chain Analysis
12.2 Growth Opportunity Analysis
12.2.1 Growth Opportunities by Type
12.2.2 Growth Opportunities by Application
12.3 Emerging Trends in the Global Breath Molecular Diagnostic Device Market
12.4 Strategic Analysis
12.4.1 New Product Development
12.4.2 Certification and Licensing
12.4.3 Mergers, Acquisitions, Agreements, Collaborations, and Joint Ventures

13. Company Profiles of the Leading Players Across the Value Chain
13.1 Competitive Analysis
13.2 Niox Group
• Company Overview
• Breath Molecular Diagnostic Device Business Overview
• New Product Development
• Merger, Acquisition, and Collaboration
• Certification and Licensing
13.3 Headway
• Company Overview
• Breath Molecular Diagnostic Device Business Overview
• New Product Development
• Merger, Acquisition, and Collaboration
• Certification and Licensing
13.4 Sunvou Medical Electronics
• Company Overview
• Breath Molecular Diagnostic Device Business Overview
• New Product Development
• Merger, Acquisition, and Collaboration
• Certification and Licensing
13.5 Caire (NGK)
• Company Overview
• Breath Molecular Diagnostic Device Business Overview
• New Product Development
• Merger, Acquisition, and Collaboration
• Certification and Licensing
13.6 Richen Holding
• Company Overview
• Breath Molecular Diagnostic Device Business Overview
• New Product Development
• Merger, Acquisition, and Collaboration
• Certification and Licensing
13.7 Meridian Bioscience
• Company Overview
• Breath Molecular Diagnostic Device Business Overview
• New Product Development
• Merger, Acquisition, and Collaboration
• Certification and Licensing
13.8 Capnia
• Company Overview
• Breath Molecular Diagnostic Device Business Overview
• New Product Development
• Merger, Acquisition, and Collaboration
• Certification and Licensing

14. Appendix
14.1 List of Figures
14.2 List of Tables
14.3 Research Methodology
14.4 Disclaimer
14.5 Copyright
14.6 Abbreviations and Technical Units
14.7 About Us
14.8 Contact Us

List of Figures

Chapter 1
Figure 1.1: Trends and Forecast for the Global Breath Molecular Diagnostic Device Market
Chapter 2
Figure 2.1: Usage of Breath Molecular Diagnostic Device Market
Figure 2.2: Classification of the Global Breath Molecular Diagnostic Device Market
Figure 2.3: Supply Chain of the Global Breath Molecular Diagnostic Device Market
Chapter 3
Figure 3.1: Trends of the Global GDP Growth Rate
Figure 3.2: Trends of the Global Population Growth Rate
Figure 3.3: Trends of the Global Inflation Rate
Figure 3.4: Trends of the Global Unemployment Rate
Figure 3.5: Trends of the Regional GDP Growth Rate
Figure 3.6: Trends of the Regional Population Growth Rate
Figure 3.7: Trends of the Regional Inflation Rate
Figure 3.8: Trends of the Regional Unemployment Rate
Figure 3.9: Trends of Regional Per Capita Income
Figure 3.10: Forecast for the Global GDP Growth Rate
Figure 3.11: Forecast for the Global Population Growth Rate
Figure 3.12: Forecast for the Global Inflation Rate
Figure 3.13: Forecast for the Global Unemployment Rate
Figure 3.14: Forecast for the Regional GDP Growth Rate
Figure 3.15: Forecast for the Regional Population Growth Rate
Figure 3.16: Forecast for the Regional Inflation Rate
Figure 3.17: Forecast for the Regional Unemployment Rate
Figure 3.18: Forecast for Regional Per Capita Income
Figure 3.19: Driver and Challenges of the Breath Molecular Diagnostic Device Market
Chapter 4
Figure 4.1: Global Breath Molecular Diagnostic Device Market by Type in 2019, 2024, and 2031
Figure 4.2: Trends of the Global Breath Molecular Diagnostic Device Market ($B) by Type
Figure 4.3: Forecast for the Global Breath Molecular Diagnostic Device Market ($B) by Type
Figure 4.4: Trends and Forecast for C13 Type in the Global Breath Molecular Diagnostic Device Market (2019-2031)
Figure 4.5: Trends and Forecast for NO Type in the Global Breath Molecular Diagnostic Device Market (2019-2031)
Figure 4.6: Trends and Forecast for H2/CO Type in the Global Breath Molecular Diagnostic Device Market (2019-2031)
Figure 4.7: Trends and Forecast for VOCs Type in the Global Breath Molecular Diagnostic Device Market (2019-2031)
Chapter 5
Figure 5.1: Global Breath Molecular Diagnostic Device Market by Application in 2019, 2024, and 2031
Figure 5.2: Trends of the Global Breath Molecular Diagnostic Device Market ($B) by Application
Figure 5.3: Forecast for the Global Breath Molecular Diagnostic Device Market ($B) by Application
Figure 5.4: Trends and Forecast for Hospitals in the Global Breath Molecular Diagnostic Device Market (2019-2031)
Figure 5.5: Trends and Forecast for Clinics in the Global Breath Molecular Diagnostic Device Market (2019-2031)
Figure 5.6: Trends and Forecast for Physical Examination Centers in the Global Breath Molecular Diagnostic Device Market (2019-2031)
Figure 5.7: Trends and Forecast for Other in the Global Breath Molecular Diagnostic Device Market (2019-2031)
Chapter 6
Figure 6.1: Trends of the Global Breath Molecular Diagnostic Device Market ($B) by Region (2019-2024)
Figure 6.2: Forecast for the Global Breath Molecular Diagnostic Device Market ($B) by Region (2025-2031)
Chapter 7
Figure 7.1: Trends and Forecast for the North American Breath Molecular Diagnostic Device Market (2019-2031)
Figure 7.2: North American Breath Molecular Diagnostic Device Market by Type in 2019, 2024, and 2031
Figure 7.3: Trends of the North American Breath Molecular Diagnostic Device Market ($B) by Type (2019-2024)
Figure 7.4: Forecast for the North American Breath Molecular Diagnostic Device Market ($B) by Type (2025-2031)
Figure 7.5: North American Breath Molecular Diagnostic Device Market by Application in 2019, 2024, and 2031
Figure 7.6: Trends of the North American Breath Molecular Diagnostic Device Market ($B) by Application (2019-2024)
Figure 7.7: Forecast for the North American Breath Molecular Diagnostic Device Market ($B) by Application (2025-2031)
Figure 7.8: Trends and Forecast for the United States Breath Molecular Diagnostic Device Market ($B) (2019-2031)
Figure 7.9: Trends and Forecast for the Mexican Breath Molecular Diagnostic Device Market ($B) (2019-2031)
Figure 7.10: Trends and Forecast for the Canadian Breath Molecular Diagnostic Device Market ($B) (2019-2031)
Chapter 8
Figure 8.1: Trends and Forecast for the European Breath Molecular Diagnostic Device Market (2019-2031)
Figure 8.2: European Breath Molecular Diagnostic Device Market by Type in 2019, 2024, and 2031
Figure 8.3: Trends of the European Breath Molecular Diagnostic Device Market ($B) by Type (2019-2024)
Figure 8.4: Forecast for the European Breath Molecular Diagnostic Device Market ($B) by Type (2025-2031)
Figure 8.5: European Breath Molecular Diagnostic Device Market by Application in 2019, 2024, and 2031
Figure 8.6: Trends of the European Breath Molecular Diagnostic Device Market ($B) by Application (2019-2024)
Figure 8.7: Forecast for the European Breath Molecular Diagnostic Device Market ($B) by Application (2025-2031)
Figure 8.8: Trends and Forecast for the German Breath Molecular Diagnostic Device Market ($B) (2019-2031)
Figure 8.9: Trends and Forecast for the French Breath Molecular Diagnostic Device Market ($B) (2019-2031)
Figure 8.10: Trends and Forecast for the Spanish Breath Molecular Diagnostic Device Market ($B) (2019-2031)
Figure 8.11: Trends and Forecast for the Italian Breath Molecular Diagnostic Device Market ($B) (2019-2031)
Figure 8.12: Trends and Forecast for the United Kingdom Breath Molecular Diagnostic Device Market ($B) (2019-2031)
Chapter 9
Figure 9.1: Trends and Forecast for the APAC Breath Molecular Diagnostic Device Market (2019-2031)
Figure 9.2: APAC Breath Molecular Diagnostic Device Market by Type in 2019, 2024, and 2031
Figure 9.3: Trends of the APAC Breath Molecular Diagnostic Device Market ($B) by Type (2019-2024)
Figure 9.4: Forecast for the APAC Breath Molecular Diagnostic Device Market ($B) by Type (2025-2031)
Figure 9.5: APAC Breath Molecular Diagnostic Device Market by Application in 2019, 2024, and 2031
Figure 9.6: Trends of the APAC Breath Molecular Diagnostic Device Market ($B) by Application (2019-2024)
Figure 9.7: Forecast for the APAC Breath Molecular Diagnostic Device Market ($B) by Application (2025-2031)
Figure 9.8: Trends and Forecast for the Japanese Breath Molecular Diagnostic Device Market ($B) (2019-2031)
Figure 9.9: Trends and Forecast for the Indian Breath Molecular Diagnostic Device Market ($B) (2019-2031)
Figure 9.10: Trends and Forecast for the Chinese Breath Molecular Diagnostic Device Market ($B) (2019-2031)
Figure 9.11: Trends and Forecast for the South Korean Breath Molecular Diagnostic Device Market ($B) (2019-2031)
Figure 9.12: Trends and Forecast for the Indonesian Breath Molecular Diagnostic Device Market ($B) (2019-2031)
Chapter 10
Figure 10.1: Trends and Forecast for the ROW Breath Molecular Diagnostic Device Market (2019-2031)
Figure 10.2: ROW Breath Molecular Diagnostic Device Market by Type in 2019, 2024, and 2031
Figure 10.3: Trends of the ROW Breath Molecular Diagnostic Device Market ($B) by Type (2019-2024)
Figure 10.4: Forecast for the ROW Breath Molecular Diagnostic Device Market ($B) by Type (2025-2031)
Figure 10.5: ROW Breath Molecular Diagnostic Device Market by Application in 2019, 2024, and 2031
Figure 10.6: Trends of the ROW Breath Molecular Diagnostic Device Market ($B) by Application (2019-2024)
Figure 10.7: Forecast for the ROW Breath Molecular Diagnostic Device Market ($B) by Application (2025-2031)
Figure 10.8: Trends and Forecast for the Middle Eastern Breath Molecular Diagnostic Device Market ($B) (2019-2031)
Figure 10.9: Trends and Forecast for the South American Breath Molecular Diagnostic Device Market ($B) (2019-2031)
Figure 10.10: Trends and Forecast for the African Breath Molecular Diagnostic Device Market ($B) (2019-2031)
Chapter 11
Figure 11.1: Porter’s Five Forces Analysis of the Global Breath Molecular Diagnostic Device Market
Figure 11.2: Market Share (%) of Top Players in the Global Breath Molecular Diagnostic Device Market (2024)
Chapter 12
Figure 12.1: Growth Opportunities for the Global Breath Molecular Diagnostic Device Market by Type
Figure 12.2: Growth Opportunities for the Global Breath Molecular Diagnostic Device Market by Application
Figure 12.3: Growth Opportunities for the Global Breath Molecular Diagnostic Device Market by Region
Figure 12.4: Emerging Trends in the Global Breath Molecular Diagnostic Device Market

List of Tables

Chapter 1
Table 1.1: Growth Rate (%, 2023-2024) and CAGR (%, 2025-2031) of the Breath Molecular Diagnostic Device Market by Type and Application
Table 1.2: Attractiveness Analysis for the Breath Molecular Diagnostic Device Market by Region
Table 1.3: Global Breath Molecular Diagnostic Device Market Parameters and Attributes
Chapter 3
Table 3.1: Trends of the Global Breath Molecular Diagnostic Device Market (2019-2024)
Table 3.2: Forecast for the Global Breath Molecular Diagnostic Device Market (2025-2031)
Chapter 4
Table 4.1: Attractiveness Analysis for the Global Breath Molecular Diagnostic Device Market by Type
Table 4.2: Market Size and CAGR of Various Type in the Global Breath Molecular Diagnostic Device Market (2019-2024)
Table 4.3: Market Size and CAGR of Various Type in the Global Breath Molecular Diagnostic Device Market (2025-2031)
Table 4.4: Trends of C13 Type in the Global Breath Molecular Diagnostic Device Market (2019-2024)
Table 4.5: Forecast for C13 Type in the Global Breath Molecular Diagnostic Device Market (2025-2031)
Table 4.6: Trends of NO Type in the Global Breath Molecular Diagnostic Device Market (2019-2024)
Table 4.7: Forecast for NO Type in the Global Breath Molecular Diagnostic Device Market (2025-2031)
Table 4.8: Trends of H2/CO Type in the Global Breath Molecular Diagnostic Device Market (2019-2024)
Table 4.9: Forecast for H2/CO Type in the Global Breath Molecular Diagnostic Device Market (2025-2031)
Table 4.10: Trends of VOCs Type in the Global Breath Molecular Diagnostic Device Market (2019-2024)
Table 4.11: Forecast for VOCs Type in the Global Breath Molecular Diagnostic Device Market (2025-2031)
Chapter 5
Table 5.1: Attractiveness Analysis for the Global Breath Molecular Diagnostic Device Market by Application
Table 5.2: Market Size and CAGR of Various Application in the Global Breath Molecular Diagnostic Device Market (2019-2024)
Table 5.3: Market Size and CAGR of Various Application in the Global Breath Molecular Diagnostic Device Market (2025-2031)
Table 5.4: Trends of Hospitals in the Global Breath Molecular Diagnostic Device Market (2019-2024)
Table 5.5: Forecast for Hospitals in the Global Breath Molecular Diagnostic Device Market (2025-2031)
Table 5.6: Trends of Clinics in the Global Breath Molecular Diagnostic Device Market (2019-2024)
Table 5.7: Forecast for Clinics in the Global Breath Molecular Diagnostic Device Market (2025-2031)
Table 5.8: Trends of Physical Examination Centers in the Global Breath Molecular Diagnostic Device Market (2019-2024)
Table 5.9: Forecast for Physical Examination Centers in the Global Breath Molecular Diagnostic Device Market (2025-2031)
Table 5.10: Trends of Other in the Global Breath Molecular Diagnostic Device Market (2019-2024)
Table 5.11: Forecast for Other in the Global Breath Molecular Diagnostic Device Market (2025-2031)
Chapter 6
Table 6.1: Market Size and CAGR of Various Regions in the Global Breath Molecular Diagnostic Device Market (2019-2024)
Table 6.2: Market Size and CAGR of Various Regions in the Global Breath Molecular Diagnostic Device Market (2025-2031)
Chapter 7
Table 7.1: Trends of the North American Breath Molecular Diagnostic Device Market (2019-2024)
Table 7.2: Forecast for the North American Breath Molecular Diagnostic Device Market (2025-2031)
Table 7.3: Market Size and CAGR of Various Type in the North American Breath Molecular Diagnostic Device Market (2019-2024)
Table 7.4: Market Size and CAGR of Various Type in the North American Breath Molecular Diagnostic Device Market (2025-2031)
Table 7.5: Market Size and CAGR of Various Application in the North American Breath Molecular Diagnostic Device Market (2019-2024)
Table 7.6: Market Size and CAGR of Various Application in the North American Breath Molecular Diagnostic Device Market (2025-2031)
Table 7.7: Trends and Forecast for the United States Breath Molecular Diagnostic Device Market (2019-2031)
Table 7.8: Trends and Forecast for the Mexican Breath Molecular Diagnostic Device Market (2019-2031)
Table 7.9: Trends and Forecast for the Canadian Breath Molecular Diagnostic Device Market (2019-2031)
Chapter 8
Table 8.1: Trends of the European Breath Molecular Diagnostic Device Market (2019-2024)
Table 8.2: Forecast for the European Breath Molecular Diagnostic Device Market (2025-2031)
Table 8.3: Market Size and CAGR of Various Type in the European Breath Molecular Diagnostic Device Market (2019-2024)
Table 8.4: Market Size and CAGR of Various Type in the European Breath Molecular Diagnostic Device Market (2025-2031)
Table 8.5: Market Size and CAGR of Various Application in the European Breath Molecular Diagnostic Device Market (2019-2024)
Table 8.6: Market Size and CAGR of Various Application in the European Breath Molecular Diagnostic Device Market (2025-2031)
Table 8.7: Trends and Forecast for the German Breath Molecular Diagnostic Device Market (2019-2031)
Table 8.8: Trends and Forecast for the French Breath Molecular Diagnostic Device Market (2019-2031)
Table 8.9: Trends and Forecast for the Spanish Breath Molecular Diagnostic Device Market (2019-2031)
Table 8.10: Trends and Forecast for the Italian Breath Molecular Diagnostic Device Market (2019-2031)
Table 8.11: Trends and Forecast for the United Kingdom Breath Molecular Diagnostic Device Market (2019-2031)
Chapter 9
Table 9.1: Trends of the APAC Breath Molecular Diagnostic Device Market (2019-2024)
Table 9.2: Forecast for the APAC Breath Molecular Diagnostic Device Market (2025-2031)
Table 9.3: Market Size and CAGR of Various Type in the APAC Breath Molecular Diagnostic Device Market (2019-2024)
Table 9.4: Market Size and CAGR of Various Type in the APAC Breath Molecular Diagnostic Device Market (2025-2031)
Table 9.5: Market Size and CAGR of Various Application in the APAC Breath Molecular Diagnostic Device Market (2019-2024)
Table 9.6: Market Size and CAGR of Various Application in the APAC Breath Molecular Diagnostic Device Market (2025-2031)
Table 9.7: Trends and Forecast for the Japanese Breath Molecular Diagnostic Device Market (2019-2031)
Table 9.8: Trends and Forecast for the Indian Breath Molecular Diagnostic Device Market (2019-2031)
Table 9.9: Trends and Forecast for the Chinese Breath Molecular Diagnostic Device Market (2019-2031)
Table 9.10: Trends and Forecast for the South Korean Breath Molecular Diagnostic Device Market (2019-2031)
Table 9.11: Trends and Forecast for the Indonesian Breath Molecular Diagnostic Device Market (2019-2031)
Chapter 10
Table 10.1: Trends of the ROW Breath Molecular Diagnostic Device Market (2019-2024)
Table 10.2: Forecast for the ROW Breath Molecular Diagnostic Device Market (2025-2031)
Table 10.3: Market Size and CAGR of Various Type in the ROW Breath Molecular Diagnostic Device Market (2019-2024)
Table 10.4: Market Size and CAGR of Various Type in the ROW Breath Molecular Diagnostic Device Market (2025-2031)
Table 10.5: Market Size and CAGR of Various Application in the ROW Breath Molecular Diagnostic Device Market (2019-2024)
Table 10.6: Market Size and CAGR of Various Application in the ROW Breath Molecular Diagnostic Device Market (2025-2031)
Table 10.7: Trends and Forecast for the Middle Eastern Breath Molecular Diagnostic Device Market (2019-2031)
Table 10.8: Trends and Forecast for the South American Breath Molecular Diagnostic Device Market (2019-2031)
Table 10.9: Trends and Forecast for the African Breath Molecular Diagnostic Device Market (2019-2031)
Chapter 11
Table 11.1: Product Mapping of Breath Molecular Diagnostic Device Suppliers Based on Segments
Table 11.2: Operational Integration of Breath Molecular Diagnostic Device Manufacturers
Table 11.3: Rankings of Suppliers Based on Breath Molecular Diagnostic Device Revenue
Chapter 12
Table 12.1: New Product Launches by Major Breath Molecular Diagnostic Device Producers (2019-2024)
Table 12.2: Certification Acquired by Major Competitor in the Global Breath Molecular Diagnostic Device Market